| Literature DB >> 35192666 |
Irene Anna Lambraki1, Melanie Cousins1, Tiscar Graells2,3, Anaïs Léger4, Patrik Henriksson3,5,6, Stephan Harbarth7, Max Troell3,5, Didier Wernli4, Peter Søgaard Jørgensen2,3, Andrew P Desbois8, Carolee A Carson9, Elizabeth Jane Parmley10, Shannon Elizabeth Majowicz1.
Abstract
INTRODUCTION: Antimicrobial resistance (AMR) is a global crisis that evolves from a complex system of factors. Understanding what factors interact is key to finding solutions. Our objective was to identify the factors influencing AMR in the European food system and places to intervene.Entities:
Mesh:
Year: 2022 PMID: 35192666 PMCID: PMC8863257 DOI: 10.1371/journal.pone.0263914
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 191 CLD Factors by 8 categories.
Description of the seven themes.
| Theme | Description of Theme |
|---|---|
|
| Describes human behaviours that can contribute to AMR spread in the environment, such as: AMU; the disposal of antibiotics, and waste from humans, animals, and industry (e.g., pharmaceutical industry); and trade and travel. |
|
| Describes the role of the market-driven economy in driving industry to higher density farming and AMU, and how changes to farming production and management practices could impact producers’ ability to cover the associated costs and remain viable. |
|
| Focuses on the impact of consumer demand for products and services (e.g., food; hospital) on AMU, and the factors (e.g., habits, personal experiences) that shape these demands. |
|
| Focuses on how prescribing practices, resources and capacity issues of the animal and human health and social care systems (public health, health care including veterinary services, social care and the communities they serve) can impact whether or how well antimicrobial stewardship and infection prevention and control measures to address AMR are carried out. |
|
| Focuses on how promoting psychological well-being and human and animal health can contribute to AMR mitigation efforts. |
|
| Identifies the impacts that social and economic inequities exert on AMR, health and well-being. |
|
| Focuses on the importance of research to develop new antimicrobials and the need for new sustainable funding models to incentivize efforts in these areas, alternatives to antimicrobials, new antimicrobial-free foods, and surveillance needs. |
Shallow and deep leverage points, associated actions, and feedback loops.
| Leverage Point | Associated Actions | Feedback Loops |
|---|---|---|
|
| ||
|
| Increasing investments in: Providing universal health care. Developing health promotion and prevention agendas and initiatives to improve health and psychological well-being. Providing insurance for farmers (e.g., to cover costs to deal with infectious outbreaks, such as methicillin-resistant Developing new antibiotics using sustainable business models that delink volume sales from manufacturer reimbursement, and by incentivizing the innovation system through public-private partnerships to address AMR. | Involved in zero feedback loops, indicating that a change in the CLD factor ‘national budgets, money, and funding’ directly impacts other parts of the system (i.e., CLD factors ‘research, surveillance, development and innovation’ and ‘health care infrastructure’) that each go on to impact other parts of the system), but is not subsequently impacted by the system. |
|
| Changing what products retail companies offer in the marketplace by: Creating collective agreements that change procurement requirements for foods and products, which puts pressure on suppliers to change production practices and systems to support antimicrobial stewardship and good farming practices. | Involved in up to 32,766 feedback loops, with a given feedback loop length containing 1 to 30 other CLD factors, indicating that a change in the CLD factor ‘retailer demand for product’ heavily impacts and is heavily impacted by many parts of the system. |
|
| Addressing AMU and AMR by: Setting antimicrobial use limits (e.g., in medicated animal feed) across nations, and AMR limits in imported foods. Providing economic incentives to promote good AMU practices in human and animal sectors. Changing public procurement requirements to promote public institutions’ (e.g., schools) purchasing of foods that support AMR mitigation efforts. Creating regulations that ensure non-antimicrobial infection prevention measures in particular settings (e.g., on-farm and abattoirs to protect against MRSA). Creating regulations about how industry can work with decision-makers, such as regulations that ensure an independent national expert group evaluates all new alternatives to antimicrobials to avoid industry directly marketing these products to decision makers. | Not applicable because the overarching factor ‘agreements, standards and regulations’ impacts the system of factors in the CLD. |
|
| ||
|
| Increasing a focus on the prevention agenda to promote health and well-being and prevent disease by: Gathering data on and sharing the impacts of interventions that promote health and well-being and any unintended consequences. | Involved in zero feedback loops, indicating that a change in the CLD factor ‘psychological health’ directly impacts other parts of the system (i.e., CLD factors ‘population vulnerabilities’; ‘chronic non-communicable diseases’; and ‘good farming practices’ that each go on to impact other CLD factors), but is not subsequently impacted by the system. |
|
| Moving scientific evidence, best practices, and success stories into action across sectors and nations to improve health and well-being and AMU practices, reduce AMR spread, and counter incorrect media messages by: Developing evidence-based AMU recommendations and providing training on these recommendations to front-line workforce across sectors (e.g., farmers and seasonal farm workers, health care and allied health care providers) to promote antimicrobial stewardship and good farming practices. Incorporating AMR, good health, and good farming practices in early school education to equip future generations with skills in stewardship and healthy living. Developing public campaigns on the benefits and risks of AMU for individuals versus the population. Marketing AMR as a One Health and One Welfare issue to create a movement for collective action like the climate change movement. Engaging media and social influencers to build relationships and their skills in delivering evidence-based messaging on AMR. Increasing advocacy among non-governmental organizations and influential figures to bring evidence-based messaging to political leaders that shape policy. | Involved in one feedback loop, indicating that a change in the CLD factor ‘understanding and awareness of scientific evidence, surveillance, and best practices’ directly impacts one other part of the system (i.e., CLD factor ‘science and academia’) and is subsequently impacted by that part of the system. |
|
| Shifting consumer and patient demand for products and services to transform widespread reliance on AMU via: Increasing transparency via labels describing animal welfare standards and the antibiotic footprint of products (e.g., food) or services (e.g., hospitals) to increase traceability, transparency, and consumer willingness to use or pay more for niche markets that could shift food production practices and put pressure on decision-makers for policy change that contribute to AMR mitigation efforts. | Involved in up to 32,766 feedback loops, with a given feedback loop length containing between 4 and 33 other CLD factors, indicating that a change in the CLD factor ‘consumer choice, demand and behaviour’ heavily impacts and is heavily impacted by many parts of the system. |
|
| Improving non-antimicrobial approaches to prevent and control infections and diseases in different settings via: Sharing success stories, for instance, where on-farm investments in infection prevention measures did not significantly change cost structures. Improving good farming practices (e.g., increasing biosecurity, vaccinations, and animal welfare standards) to raise and keep food animals healthy. Improving the level of hygiene in human health care to prevent disease. Implementing evidence-based interventions and recommendations to prevent or control infection and AMR spread (e.g., advising people at high risk of MRSA to not work in swineries). Developing devices that notify health care providers to adhere to workplace infection prevention measures (e.g., wash hands, etc). | Involved in >30,000 feedback loops, with a given feedback containing upwards of 33 CLD factors, indicating that a change in each of the five CLD factors ‘non-antimicrobial disease prevention and infection control in plant agriculture’; ‘non-antimicrobial infection prevention and control by public’; ‘non-antimicrobial disease prevention and control in health and social care settings’; ‘non-antimicrobial infection prevention and control in other social institutions’; and ‘non-antimicrobial infection control on farms of food producing animals’ heavily impacts and is heavily impacted by many parts of the system. |
|
| ||
|
| ||
|
| ||
|
| ||
|
| Focusing research efforts in the following areas to fill knowledge gaps and explore (new) responses to AMR: Conducting research on gut microflora and the microbiome in humans and animals to uncover alternatives to AMU and how to promote health and prevent disease. Developing precise measures for surveillance on AMU (e.g., how much antimicrobials are used versus discarded) to trace transmission of antimicrobial residues in different settings (e.g., food, environment). Identifying indicators and metrics to assess and determine what places in the system are effective targets for intervention. Capturing data via surveillance on AMR-related deaths for recording on death certificates to make the impacts of AMR tangible. Developing rapid diagnostics that distinguish between microorganisms to inform AMU treatment recommendations for humans, animals, and plants. Developing block chain technology to improve traceability of the processes involved from farm to fork and detect infectious outbreaks. Learning how to develop cost-effective behaviour change interventions that are tailored to high-risk populations and settings. | Involved in up to 32,766 feedback loops, with a given feedback loop containing between 2 and 30 other CLD factors, indicating that the CLD factor ‘research, surveillance, development, and innovation’ heavily impacts and is heavily impacted by many parts of the system. |
|
| Increasing collaboration by: Developing information networks between nations, governments, and industries to share benchmarking data to determine how AMR initiatives (e.g., National Action Plans for AMR) impact different sectors and to foster adaptive learning. Building trust between human and particularly agricultural/animal sectors to motivate sharing of information about AMU, AMR, and actions without fear of negative economic consequences. | Not applicable because the overarching factor ‘collaboration’ impacts the system of factors in the CLD. |
|
| Changing the intent (i.e., values and goals) that drive the system by leadership (from individuals to formal leadership bodies): Creating the vision and goals of how we want the world to be and what values we want to uphold (i.e., economic profits or health and wellbeing as our indicator of progress) and actions needed to achieve and maintain success. Implementing the Sustainable Development Goals, and determining the infrastructure needs and actions necessary to work through conflicting agendas across nations. | Not applicable because the overarching factor ‘leadership’ impacts the system of factors in the CLD. |